esis Quotes & Charts Company Information & Advice Consensus Chart Analysis Derivatives Forum List Portfolio Alerts
Transgene Transgene boosted by the results of a study
01/09/14 09:06 - Reuters 0 Comment (s)
The main preliminary results of a phase II study evaluating TG4010, a treatment against lung cancer, have shown the effectiveness of a biomarker, which allows the biotech to consider the initiation of the Phase 3 the study.
PARIS, Jan. 9 (Reuters) - At 9:05, the Transgene share gains 8.23% to 10 euros, the largest increase in the CAC Mid & Small index
Transgene has signed an exclusive option agreement with Novartis for the development and commercialization of TG4010.
(The statement: http://r.reuters.com/tak85v) (Alexandre Boksenbaum Granier)
Transgene Transgene boosted by the results of a study
01/09/14 09:06 - Reuters 0 Comment (s)
The main preliminary results of a phase II study evaluating TG4010, a treatment against lung cancer, have shown the effectiveness of a biomarker, which allows the biotech to consider the initiation of the Phase 3 the study.
PARIS, Jan. 9 (Reuters) - At 9:05, the Transgene share gains 8.23% to 10 euros, the largest increase in the CAC Mid & Small index
Transgene has signed an exclusive option agreement with Novartis for the development and commercialization of TG4010.
(The statement: http://r.reuters.com/tak85v) (Alexandre Boksenbaum Granier)
0 comments:
Post a Comment